Differential susceptibility to striatal neurodegeneration induced by quinolinic acid and kainate in inbred, outbred and hybrid mouse strains

European Journal of Neuroscience

Volumn 24, Issue 11, 2006, Pages 3134-3140

  McLin, Jessica Pilar ^a   Thompson, Leslie Michels ^a,b   Steward, Oswald ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epilepsy; Huntington's disease; Transgenic

Indexed keywords

EXCITOTOXIN; KAINIC ACID; QUINOLINIC ACID;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CROSS BREEDING; DISEASE COURSE; EXCITOTOXICITY; GENETIC SUSCEPTIBILITY; HEREDITY; HUNTINGTON CHOREA; INBREEDING; MALE; MOUSE; MOUSE STRAIN; NERVE DEGENERATION; NONHUMAN; OUTBREEDING; PHENOTYPE; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALS; CHIMERA; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; GENETIC PREDISPOSITION TO DISEASE; HUNTINGTON DISEASE; KAINIC ACID; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, INBRED DBA; MICE, INBRED ICR; NERVE DEGENERATION; NEURONS; NEUROTOXINS; PHENOTYPE; QUINOLINIC ACID; SPECIES SPECIFICITY;

EID: 33750381007     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.05198.x     Document Type: Article

References (19)

1. Beal, M.F., Kowall, N.W., Ellison, D.W., Mazurek, M., Swartz, K.J. & Martin, J.B. (1986) Replication of the neurochemical characteristics on Huntington's disease by quinolinic acid. Nature, 321, 168-173.
2. Ben-Ari, Y. & Cossart, R. (2000) Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci., 23, 580-587.
3. van Dellen, A. & Hannan, A.J. (2004) Genetic and environmental factors in the pathogenesis of Huntington's disease. Neurogenetics, 5, 9-17.
4. Hansson, O., Petersen, A., Leist, M., Nicotera, P., Castilho, R.F. & Brundin, P. (1999) Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proceedings of the National Academy of Sciences of the United States of America, 96, 8727-8732.
5. Hansson, O., Castilho, R.F., Korhonen, L., Lindholm, D., Bates, G.P. & Brundin, P. (2001a) Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length. Journal of Neurochemistry, 78, 694-703.
6. Hansson, O., Guatteo, E., Mercuri, N.B., Bernardi, G., Li, X.J., Castilho, R.F. & Brundin, P. (2001b) Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene. Eur. J. Neurosci., 14, 1492-1504.
7. Landles, C. & Bates, G. (2004) Huntingtin and the molecular pathogenesis of Huntington's disease. Eur. Mol. Biol. Organiz., 5, 958-963.
8. McKhann, G.M., Wenzel, H.J., Robbins, C.A., Sosunov, A.A. & Schwartzkroin, P.A. (2003) Mouse strain difference in kainic acid sensitivity, seizure behavior, mortality and hippocampal pathology. Neuroscience, 122, 551-561.
9. McLin, J.P. & Steward, O. (2006) Comparison of seizure phenotype and neurodegeneration induced by systemic kainic acid in inbred, outbred, hybrid and congenic mouse strains. Eur. J. Neurosci, 24, 2191-2202.
10. Menalled, L.B. & Chesselet, M.F. (2002) Mouse models of Huntington's disease. Trends Pharmacol. Sci., 23, 32-39.
11. Schauwecker, P.E. (2003) Genetic basis of kainate-induced excitotoxicity in mice: phenotypic modulation of seizure-induced cell death. Epilepsy Res., 55, 201-210.
12. Schauwecker, P.E. (2005) Susceptibility to excitotoxic and metabolic striatal neurodegeneration in the mouse in genotype dependent. Brain Res., 1040, 112-120.
13. Schauwecker, P.E. & Steward, O. (1997) Genetic determinants of susceptibility to excitotoxic cell death: Implications for gene targeting approaches. Proc. Natl Acad. Sci. U.S.A., 94, 4103-4108.
14. Schauwecker, P.E., Williams, R.W. & Santos, J.B. (2004) Genetic control of sensitivity to hippocampal cell death induced by kainic acid: a quantitative trait loci analysis. J. Comp. Neurol., 477, 96-107.
15. Schmued, L.C., Albertson, C. & Slikker, W. (1997) Fluoro-Jade: A novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Research, 751, 37-46.
16. Schmued, L.C., & Hopkins, K.J. (2000a) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Research, 874, 123-130.
17. Schmued, L.C., & Hopkins, K.J. (2000b) Fluoro-Jade: Novel fluorochromes for detecting toxicant-induced neuronal degeneration. Toxicologic Pathology, 28, 91-99.
18. Schwarcz, R., Whetsell, W.O. & Mangano, R.M. (1983) Quinolinic acid - an endogenous metabolite that produces axon-sparing lesions in rat-brain. Science, 219, 316-318.
19. Steward, O., Schauwecker, P.E., Guth, L., Zhang, Z.Y., Fujiki, M., Inman, D., Wrathall, J., Kempermann, G., Gage, F.H., Saatman, K.E., Raghupathi, R. & McIntosh, T. (1999) Genetic approaches to neurotrauma research: Opportunities and potential pitfalls of murine models. Exp. Neurol., 157, 19-42.